Physician profile
John Patrick Mccaskey
NPI 1114306727
$752.15
in general payments reported to CMS, 2019-2025
12 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.50 · 2021: $24.98 · 2022: $186 · 2023: $187 · 2024: $190 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $266.65 | 2023-2025 | |
| Intuitive Surgical, INC. | $128.67 | 2022 | |
| Glaxosmithkline, LLC. | $126.08 | 2020-2025 | Shingrix, Arexvy |
| Boston Scientific Corporation | $67.69 | 2020-2024 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Exact Sciences Corporation | $41.02 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $36.95 | 2022-2023 | Venaseal |
| Linus Health, INC. | $17.79 | 2023 | |
| Stryker Corporation | $15.84 | 2025 | Clottriever Bold Catheter |
| Merck Sharp & Dohme LLC | $14.29 | 2022 | |
| Corcept Therapeutics | $13.67 | 2025 | Korlym |
| E.R. Squibb & Sons, L.L.C. | $11.79 | 2021 | |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mccaskey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.